It's a simple word that has developed a sinister connotation: algorithm. For many of us, algorithms help determine what we watch, read and listen to — in the process, confirming our tastes and biases, ...

Megan Cerullo is a New York-based reporter for CBS MoneyWatch covering small business, workplace, health care, consumer spending and personal finance topics. She regularly appears on CBS News 24/7 to ...

To preface this discussion, some level of inflation (rising prices) is perfectly normal and healthy. Since January 2012, the Federal Open Market Committee (FOMC)-- the 12-person body responsible for ...

KNOXVILLE, Tenn. (WATE) — As discussions of data centers that require high power loads continue to develop, the Tennessee Valley Authority is considering changing its rates in a way to accommodate the ...

In a battle of two Heisman winners, Baker Mayfield and the Tampa Bay Buccaneers will head to Paycor Stadium to face Joe Burrow and the Cincinnati Bengals as part of Sunday’s afternoon schedule.

After three days of marquee matchups being unveiled, the 2026 NFL regular season schedule has arrived with the league's full Thursday reveal. Week 1 -- and the season -- kicks off as usual with the ...

Abstract: In the last decade, 1-bit synthetic aperture radar (SAR) imaging has been proposed, which uses 1-bit quantized echo data for scene reconstruction, offering substantial reductions in system ...

Abstract: To enhance the motion adaptability of wheel-legged robot in complex environments, a novel data-driven value iteration (VI) control algorithm based on adaptive dynamic programming (ADP) is ...

Amazon One Medical launched a GLP-1 program integrating obesity care with Amazon Pharmacy. Pricing for the popular weight loss drugs will begin at as low as $25 per month with insurance. Shares of ...

Representatives of the crypto and banking industries are meeting with legislative staffers on Thursday and Friday to review revised compromise language on stablecoin yield provisions in the market ...

Structure Therapeutics reported highly positive Phase 2 ACCESS II data for aleniglipron, achieving ~16% placebo-adjusted weight loss with strong statistical significance and no plateau. Aleniglipron’s ...

Structure Therapeutics has touted the 16% weight loss—about 39 pounds—seen by aleniglipron as the best results yet for an oral GLP-1 drug, as the obesity biotech readies the candidate for phase 3. The ...